mGluR6 Protein

mGluR6 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">mGluR6 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Description</td>
</tr>
<tr>
<td class="label">N-terminal VFT domain</td>
<td>Large extracellular domain (~400 aa) with ligand binding site</td>
</tr>
<tr>
<td class="label">Cysteine-rich domain</td>
<td>Linker with structural disulfide bonds</td>
</tr>
<tr>
<td class="label">7 Transmembrane domain</td>
<td>Classic seven-helix bundle</td>
</tr>
<tr>
<td class="label">C-terminal tail</td>
<td>Intracellular domain with unique features</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>ON-bipolar (mGluR6)</td>
</tr>
<tr>
<td class="label">Glutamate response</td>
<td>Depolarization → hyperpolarization</td>
</tr>
<tr>
<td class="label">Receptor type</td>
<td>mGluR6</td>
</tr>
<tr>
<td class="label">Light response</td>
<td>ON (light = depolarization block)</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">AAV-GRM6</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">CRISPR</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Optogenetics</td>
<td>Experimental</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Selectivity</td>
</tr>
<tr>
<td class="label">L-AP4</td>
<td>Group III agonist</td>
</tr>
<tr>
<td class="label">MSDC-0160</td>

mGluR6 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">mGluR6 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Description</td>
</tr>
<tr>
<td class="label">N-terminal VFT domain</td>
<td>Large extracellular domain (~400 aa) with ligand binding site</td>
</tr>
<tr>
<td class="label">Cysteine-rich domain</td>
<td>Linker with structural disulfide bonds</td>
</tr>
<tr>
<td class="label">7 Transmembrane domain</td>
<td>Classic seven-helix bundle</td>
</tr>
<tr>
<td class="label">C-terminal tail</td>
<td>Intracellular domain with unique features</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>ON-bipolar (mGluR6)</td>
</tr>
<tr>
<td class="label">Glutamate response</td>
<td>Depolarization → hyperpolarization</td>
</tr>
<tr>
<td class="label">Receptor type</td>
<td>mGluR6</td>
</tr>
<tr>
<td class="label">Light response</td>
<td>ON (light = depolarization block)</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">AAV-GRM6</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">CRISPR</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Optogenetics</td>
<td>Experimental</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Selectivity</td>
</tr>
<tr>
<td class="label">L-AP4</td>
<td>Group III agonist</td>
</tr>
<tr>
<td class="label">MSDC-0160</td>
<td>mGluR6 PAM</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

mGluR6 (Metabotropic Glutamate Receptor 6), encoded by the GRM6 gene (also known as GRM6 or mGlu6), is a member of the Group III metabotropic glutamate receptor family. Unlike other mGluR subtypes that are widely distributed throughout the brain, mGluR6 exhibits highly restricted expression, being predominantly localized to retinal ON-bipolar cells. This unique cellular distribution makes mGluR6 essential for scotopic (low-light) vision and the processing of visual information under dim lighting conditions [@weiler2024].

The receptor's critical role in vision is highlighted by the fact that mutations in GRM6 cause Congenital Stationary Night Blindness (CSNB), a non-progressive retinal disorder characterized by impaired night vision, reduced visual acuity, and abnormal electroretinogram (ERG) findings. Beyond its essential role in normal vision, mGluR6 has attracted interest as a potential therapeutic target for retinal degenerative diseases and as a model for understanding GPCR signaling in specialized sensory systems.

Gene and Protein Structure

Gene Organization

The GRM6 gene (Gene ID: 2915) is located on chromosome 5q33.1 in humans. The gene spans approximately 25 kb and contains 9 exons. Alternative splicing produces multiple mRNA isoforms, although the functional significance of these variants is not fully characterized. The GRM6 promoter contains regulatory elements specific to retinal expression.

Key features:

• Retina-specific expression elements
• Alternative splicing in the C-terminal tail
• Conservation across vertebrate species

Protein Architecture

mGluR6 shares the class C GPCR architecture with other family members:

mGluR6 has the lowest glutamate affinity among all mGluR subtypes, requiring higher glutamate concentrations for activation. This high threshold is essential for its function as an ON-bipolar cell detector of light decrement.

Post-translational Modifications

• N-linked glycosylation in extracellular domains
• Disulfide bonds in the cysteine-rich domain
• Phosphorylation at serine/threonine residues
• Palmitoylation for membrane localization

Unique Structural Features

• Proline-rich region in intracellular loop 3
• Distinct C-terminal PDZ-binding motif
• Highly conserved ligand binding domain

Normal Function in the Retina

ON-Bipolar Cell Expression

mGluR6 is exclusively expressed in retinal ON-bipolar cells: [@davidson2022]

Signal Transduction Cascade

The mGluR6 signaling cascade is unique among mGluRs:

Glutamate → mGluR6 → Gi/o → PDE6 → cGMP ↓ → Channel closure → Hyperpolarization

This cascade is similar to phototransduction but initiated by glutamate rather than light.

Key Steps:

Visual Processing

mGluR6 is essential for scotopic vision: [@tattoli2023]

• Scotopic threshold: Detects single photon events
• Contrast enhancement: Amplifies light increments
• Temporal processing: Rapid response to light changes
• Spatial integration: Collects input from photoreceptor clusters

Comparison with OFF-Bipolar Cells

Role in Disease

Congenital Stationary Night Blindness (CSNB)

Mutations in GRM6 cause CSNB: [@tappe2023]

Clinical Features

• Impaired night vision from birth
• Normal daytime vision
• Reduced visual acuity
• Abnormal ERG (electroretinogram)

Genetic Basis

• Autosomal recessive inheritance
• Over 30 pathogenic mutations identified
• Mutations affect receptor function, trafficking, or expression

Pathophysiology

• Loss of mGluR6 function disrupts ON-bipolar cell signaling
• Impaired scotopic vision due to defective signal transmission
• Normal photopic vision preserved (cone system intact)

Retinal Degeneration

mGluR6 alterations in retinal disease: [@kato2023]

• Retinitis pigmentosa: Secondary changes in mGluR6 expression
• Age-related macular degeneration: Altered mGluR6 signaling
• Diabetic retinopathy: Potential involvement in vascular changes

Therapeutic Approaches

mGluR6 modulators are being explored: [@williams2024]

• Agonists: May enhance residual mGluR6 function
• PAMs: Allosteric enhancement of receptor signaling
• Gene therapy: Viral vector delivery of wild-type GRM6

Therapeutic Targeting

Gene Therapy

mGluR6 is an excellent candidate for gene therapy: [@anderson2024]

Small Molecule Modulators

mGluR6-specific compounds are limited due to its restricted expression:

Considerations

Signaling Pathways

mGluR6 couples to Gi/o proteins, similar to other Group III receptors:

Unique Signaling Features

Unlike other mGluRs, mGluR6 activates phosphodiesterase 6 (PDE6), the same enzyme activated by rhodopsin in phototransduction. This makes mGluR6 the only GPCR that directly activates PDE6 in the retina.

Related Pages

• [GRM6 Gene](/genes/grm6)
• [mGluR4 Protein](/proteins/mglur4-protein)
• [mGluR7 Protein](/proteins/mglur7-protein)
• [Retina](/brain-regions/retina)
• [Phototransduction](/mechanisms/phototransduction)
• [Retinal Bipolar Cells](/cell-types/bipolar-cells-retina)
• [Congenital Stationary Night Blindness](/diseases/congenital-stationary-night-blindness)

External Links

• [UniProt: Q14840](https://www.uniprot.org/uniprot/Q14840)
• [IUPHAR: mGluR6](https://www.guidetopharmacology.org/GRAC/receptorDisplayForward?receptorId=421)
• [GeneCards: GRM6](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRM6)
• [OMIM: 604096](https://omim.org/entry/604096)
• [Retina International](https://www.retina-international.org/)

References